Published in Clinicoecon Outcomes Res on February 24, 2010
Making sense of mobile health data: an open architecture to improve individual- and population-level health. J Med Internet Res (2012) 1.17
Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol (2011) 1.07
How I do it: a practical database management system to assist clinical research teams with data collection, organization, and reporting. Acad Radiol (2015) 0.85
Leveraging EHR data for outcomes and comparative effectiveness research in oncology. Curr Oncol Rep (2012) 0.84
The automatic clinical trial: leveraging the electronic medical record in multisite cancer clinical trials. Curr Oncol Rep (2012) 0.84
Implementing a regional oncology information system: approach and lessons learned. Curr Oncol (2014) 0.75
The PSA tracker: a computerised health care system initiative in Northern Ireland. Ulster Med J (2013) 0.75
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA (2006) 24.01
Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA (1998) 12.60
Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med (2003) 6.47
Missing clinical information during primary care visits. JAMA (2005) 6.15
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Triple-negative breast cancer: therapeutic options. Lancet Oncol (2007) 4.80
Electronic health records: just around the corner? Or over the cliff? Ann Intern Med (2005) 4.74
Integrated personal health records: transformative tools for consumer-centric care. BMC Med Inform Decis Mak (2008) 3.68
Definition, structure, content, use and impacts of electronic health records: a review of the research literature. Int J Med Inform (2007) 3.53
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol (2006) 2.92
Review: use of electronic medical records for health outcomes research: a literature review. Med Care Res Rev (2009) 2.68
Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer (2008) 2.60
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med (1999) 2.42
Electronic medical records for clinical research: application to the identification of heart failure. Am J Manag Care (2007) 2.18
Which physicians and practices are using electronic medical records? Health Aff (Millwood) (2005) 2.15
Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol (1994) 2.04
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther (2006) 1.64
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades? Ann Oncol (2002) 1.46
Human subjects issues and IRB review in practice-based research. Ann Fam Med (2005) 1.44
Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev (2008) 1.42
Risks, barriers, and benefits of EHR systems: a comparative study based on size of hospital. Perspect Health Inf Manag (2006) 1.30
Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 1.23
A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev (1998) 1.22
Electronic health records: high-quality electronic data for higher-quality clinical research. Inform Prim Care (2007) 1.16
Ensuring Continuity of Care Through Electronic Health Records: Recommendations From the ASCO Electronic Health Record Roundtable. J Oncol Pract (2007) 1.15
Practical applications of usability theory to electronic data collection for clinical trials. Contemp Clin Trials (2005) 1.14
Treatment preferences in recurrent ovarian cancer. Gynecol Oncol (2002) 1.14
Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers. Ann Oncol (2007) 1.14
Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control (1999) 1.13
Molecular epidemiology of cancer. CA Cancer J Clin (2005) 1.08
Cancer health disparities: what we have done. Am J Med Sci (2008) 1.02
Patient recall and recall bias of health state and health status. Expert Rev Pharmacoecon Outcomes Res (2004) 1.02
Electronic health records. J Oncol Pract (2005) 0.99
Impact of computerised chemotherapy prescriptions on the prevention of medication errors. Clin Transl Oncol (2006) 0.92
A history of the shift toward full computerization of medicine. J Oncol Pract (2005) 0.90
Electronic health records: a primer for practicing physicians. Cleve Clin J Med (2007) 0.89
Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience. Ann Oncol (2008) 0.85
Attitudes to chemotherapy in patients with ovarian cancer. Gynecol Oncol (2004) 0.78
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18
Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am (2005) 7.56
Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 3.78
Obesity and risk for chronic renal failure. J Am Soc Nephrol (2006) 3.67
Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys. J Natl Cancer Inst (2008) 2.64
Test-retest reliability of the Women's Health Initiative physical activity questionnaire. Med Sci Sports Exerc (2009) 1.48
Baseline characteristics and predictors of outcome in patients with myelodysplastic syndromes living in Western Pennsylvania. Leuk Lymphoma (2011) 1.42
Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine. Vaccine (2013) 1.40
An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol (2013) 1.29
Primary and revision arthroplasty surgery caseloads in the United States from 1990 to 2004. J Arthroplasty (2008) 1.26
Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol (2009) 1.19
Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol (2007) 1.18
Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol (2004) 1.13
Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg (2002) 1.04
Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health (2013) 1.03
Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006. Am J Hematol (2010) 1.01
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union. Eur J Haematol (2014) 0.98
The prevalence of X-linked hypohidrotic ectodermal dysplasia (XLHED) in Denmark, 1995-2010. Eur J Med Genet (2013) 0.96
Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol (2010) 0.93
Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leuk Res (2009) 0.91
Use of nonaspirin NSAIDs and risk of lung cancer. Int J Cancer (2005) 0.89
Cancer mortality and oil production in the Amazon Region of Ecuador, 1990-2005. Int Arch Occup Environ Health (2008) 0.83
An ecological study of cancer mortality rates in high altitude counties of the United States. High Alt Med Biol (2012) 0.79
Factors affecting receipt of chemotherapy in women with breast cancer. Int J Womens Health (2010) 0.79
Androgen deprivation therapy and cataract incidence among elderly prostate cancer patients in the United States. Ann Epidemiol (2010) 0.79
Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol (2007) 0.78
Occupational exposure to airborne asbestos from coatings, mastics, and adhesives. J Expo Anal Environ Epidemiol (2004) 0.76
Cesarean Section and Risk of Childhood Acute Lymphoblastic Leukemia in a Population-Based, Record-Linkage Study in California. Am J Epidemiol (2016) 0.75
A multisource approach to improving epidemiologic estimates: application to global B-cell malignancies. ISRN Oncol (2012) 0.75
709: SEVERE RSV DISEASE AMONG CHILDREN WITH CHD IN THE FIRST TWO YEARS OF LIFE. Crit Care Med (2016) 0.75
Parental age and risk of pediatric cancer in the offspring: a population-based record-linkage study in California. Am J Epidemiol (2017) 0.75
AACR Special Conference: The Molecular and Genetic Epidemiology of Cancer. Cancer Epidemiol Biomarkers Prev (2003) 0.75
Simulation tests to assess occupational exposure to airborne asbestos from artificially weathered asphalt-based roofing products. Ann Occup Hyg (2010) 0.75
Neck injuries among electric utility workers, 1995-2007. J Occup Environ Med (2010) 0.75
The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim. J Med Econ (2012) 0.75